Production and characterization of recombinant scFv against digoxin by phage display technology

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

Volumn 32, Issue 3, 2013, Pages 172-179

  Alirezapour, Behruz ^a   Rajabibazl, Masoumeh ^b   Rasaee, Mohhamad Javad ^a   Omidfar, Kobra ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

AR 85; COMPLEMENTARY DNA; DIGOXIN; MONOCLONAL ANTIBODY; POLYPEPTIDE; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOPANNING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE INSERTION; HYBRIDOMA; MOUSE; NONHUMAN; PHAGE DISPLAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; BACTERIOPHAGES; CELL SURFACE DISPLAY TECHNIQUES; DIGOXIN; DNA, COMPLEMENTARY; GENE AMPLIFICATION; MICE; MICE, INBRED BALB C; PEPTIDE LIBRARY; RECOMBINANT PROTEINS; RNA, MESSENGER; SINGLE-CHAIN ANTIBODIES;

EID: 84881575814     PISSN: None     EISSN: 21679436     Source Type: Journal    
DOI: 10.1089/mab.2012.0093     Document Type: Article

References (28)

1. Smith TW, Butler VP Jr, Haber E, Fozzard H, Marcus FI, Bremner WF, Schulman IC, and Phillips A: Treatment of lifethreatening digitalis intoxication with digoxin-specific Fab antibody fragments. N Engl J Med 1982;307: 1357-1362.
2. Jann Quaife E, Banner W, Vernon DD, and Christensen DW: Failure of CAVH to remove digoxin-Fab complex in piglets. Clin Toxicol 1990;28: 61-68.
3. Brodeur PH, and Riblet R: The immunoglobulin heavy chain variable region (Igh-V) locus in the mouse. I. One hundred Igh-V genes comprise seven families of homologous genes. Eur J Immunol 1984;14: 922-930.
4. Kabat EA, andWu T: Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, minigenes, and complementarity-determining regions to binding of antibody-combining sites. J Immunol 1991;147: 1709.
5. Brodeur PH, Osman G, Mackle J, and Lalor T: The organization of the mouse Igh-V locus. Dispersion, interspersion, and the evolution of VH gene family clusters. J Exp Med 1988;168: 2261-2278.
6. Livant D, Blatt C, and Hood L: One heavy chain variable region gene segment subfamily in the BALB/c mouse contains 500-1000 or more members. Cell 1986;47: 461-470.
7. Howard GC, and Bethell DR: Basic methods in antibody production and characterization.CRCPress, Boca Raton, FL, 1995.
8. Gavilondo JV, and Larrick JW: Antibody engineering at the millennium. Biotechniques 2000;29: 128-145.
9. Hollman A: Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata. BMJ 1996;312: 912.
10. Ikeda Y, Fujii Y, Umemura M, Hatakeyama T, Morita M, and Yamazaki M: Quantitative determination of cardiac glycosides in Digitalis lanata leaves by reversed-phase thinlayer chromatography. J Chromatogr 1996;746: 255-260.
11. Katzung BG: Basic and Clinical Pharmacology. Appleton and Lange, Prentice Hall, London, 2007.
12. Ball WJ, Kasturi R, Dey P, Tabet M, O'Donnell S, Hudson D, and Fishwild D: Isolation and characterization of human monoclonal antibodies to digoxin. J Immunol 1999;163: 2291.
13. Seifen E: Cardiac glycosides and other drugs used in myocardial insufficiency.Modern Pharmacology with Clinical Applications, 3rd ed. Little, Brown, Boston, 1997, pp. 162-174.
14. Kashanian S, Rasaee M, Paknejad M, Omidfar K, Pour-Amir M, and Rajabi BM: Preparation and characterization of monoclonal antibody against digoxin. Hybridoma Hybridomics 2002;21: 375-379.
15. Kontermann R: Antibody Engineering. Springer Verlag, Berlin, 2010.
16. Barbass III CF, Barbas CF, Burton DR, Scott JK, and Silverman GJ: Phage Display: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2009.
17. Sambrook J, and Russell DW: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2010.
18. Tang Y, Jiang N, Parakh C, and Hilvert D: Selection of linkers for a catalytic single-chain antibody using phage display technology. J Biol Chem 1996;271: 15682-15686.
19. Huston JS, Mudgett-Hunter M, Tai MS, McCartney J, Warren F, Haber E, and Oppermann H: Protein engineering of single-chain Fv analogs and fusion proteins. Methods Enzymol 1991;203: 46-88.
20. Atwell JL, Breheney KA, Lawrence LJ, McCoy AJ, Kortt AA, and Hudson PJ: scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies. Protein Eng 1999;12: 597-604.
21. Le Gall F, Kipriyanov SM, Moldenhauer G, and Little M: Di-, tri-and tetrameric single chain Fv antibody fragments against human CD19: effect of valency on cell binding. FEBS Lett 1999;453: 164-168.
22. Mead D, and Kemper B: Chimeric single-stranded DNA phage-plasmid cloning vectors. Biotechnology 1988;10: 85.
23. Skerra A, and Pluckthun A: Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science 1988; 240: 1038.
24. Clackson T, Hoogenboom HR, Griffiths AD, and Winter G: Making antibody fragments using phage display libraries. Nature 1991;352: 624-628.
25. Dall'Acqua W, and Carter P: Antibody engineering. Curr Opin Struct Biol 1998;8: 443-450.
26. Griffiths AD, and Duncan AR: Strategies for selection of antibodies by phage display. Curr Opin Biotechnol 1998;9: 102-108.
27. Lilley GG, Dolezal O, Hillyard CJ, Bernard C, and Hudson PJ: Recombinant single-chain antibody peptide conjugates expressed in Escherichia coli for the rapid diagnosis of HIV. J Immunol Methods 1994;171: 211-226.
28. Wahyono D, Piechaczyk M, Scherrmann J, Girard C, Grenier J, Mani JC, Bastide J, and Pau B: Highly specific radioimmunoassay for digoxin using a monoclonal antibody selected for lack of interference by digoxin-like immunoreactive substances in cord blood sera. Ther Drug Monitor 1991;13: 113.